Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 2241
  • Home
  • Print this page
  • Email this page
SYMPOSIUM: KERATOCONUS
Year : 2013  |  Volume : 61  |  Issue : 8  |  Page : 428-429

Current status of accelerated corneal cross-linking


IROC Innocross AG, Technoparkstrasse 1, Zurich, Switzerland

Correspondence Address:
Michael Mrochen
PhD, IROC Innocross AG, Zurich, Switzerland

Login to access the Email id

Source of Support: None, Conflict of Interest: Shareholder of IROC Innocross AG.


DOI: 10.4103/0301-4738.116075

Rights and Permissions

Corneal cross-linking with riboflavin is a technique to stabilize or reduce corneal ectasia, in diseases such as keratoconus and post-laser-assisted in situ keratomileusis (LASIK) ectasia. There is an interest by patient as well as clinicians to reduce the overall treatment time. Especially, the introduction of corneal cross-linking in combination with corneal laser surgery demands a shorter treatment time to assure a sufficient patient flow. The principles and techniques of accelerated corneal cross-linking is discussed.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed3456    
    Printed45    
    Emailed1    
    PDF Downloaded506    
    Comments [Add]    
    Cited by others 9    

Recommend this journal